Baupost Group Reports 42.5% Stake in Keryx Biopharmaceuticals, Inc. (KERX)
Tweet Send to a Friend
In a 13D filing on Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), hedge fund Baupost Group disclosed a 42.53%, or 59,214,137 share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
